Literature DB >> 35004955

Why surgeons care about systemic chemotherapy for pancreatic cancer?

Stefan Heinrich1.   

Abstract

Entities:  

Year:  2021        PMID： 35004955      PMCID： PMC8683925          DOI： 10.21037/hbsn-21-398

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  16 in total

1.  Locally Advanced Pancreatic Cancer: Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients.

Authors:  Thilo Hackert; Milena Sachsenmaier; Ulf Hinz; Lutz Schneider; Christoph W Michalski; Christoph Springfeld; Oliver Strobel; Dirk Jäger; Alexis Ulrich; Markus W Büchler
Journal:  Ann Surg       Date:  2016-09       Impact factor: 12.969

2.  Preoperative assessment of the resectability of pancreatic ductal adenocarcinoma on CT according to the NCCN Guidelines focusing on SMA/SMV branch invasion.

Authors:  Sae-Jin Park; Siwon Jang; Joon Koo Han; Hongbeom Kim; Wooil Kwon; Jin-Young Jang; Kyoung-Bun Lee; Haeryoung Kim; Dong Ho Lee
Journal:  Eur Radiol       Date:  2021-03-19       Impact factor: 5.315

3.  Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies.

Authors:  Hiroshi Haeno; Mithat Gonen; Meghan B Davis; Joseph M Herman; Christine A Iacobuzio-Donahue; Franziska Michor
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

4.  Pancreatic resection for cancer-the Heidelberg technique.

Authors:  Martin Schneider; Oliver Strobel; Thilo Hackert; Markus W Büchler
Journal:  Langenbecks Arch Surg       Date:  2019-11-14       Impact factor: 3.445

5.  Completion of Adjuvant Chemotherapy After Upfront Surgical Resection for Pancreatic Cancer Is Uncommon Yet Associated With Improved Survival.

Authors:  Ariella M Altman; Keith Wirth; Schelomo Marmor; Emil Lou; Katherine Chang; Jane Y C Hui; Todd M Tuttle; Eric H Jensen; Jason W Denbo
Journal:  Ann Surg Oncol       Date:  2019-07-16       Impact factor: 5.344

Review 6.  Pancreatic Cancer: A Review.

Authors:  Wungki Park; Akhil Chawla; Eileen M O'Reilly
Journal:  JAMA       Date:  2021-09-07       Impact factor: 157.335

7.  Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis.

Authors:  Ali A Mokdad; Rebecca M Minter; Hong Zhu; Mathew M Augustine; Matthew R Porembka; Sam C Wang; Adam C Yopp; John C Mansour; Michael A Choti; Patricio M Polanco
Journal:  J Clin Oncol       Date:  2016-09-30       Impact factor: 44.544

Review 8.  Clinical Trials of Systemic Chemotherapy for Resectable Pancreatic Cancer: A Review.

Authors:  Michail N Mavros; Dimitrios Moris; Paul J Karanicolas; Matthew H G Katz; Eileen M O'Reilly; Timothy M Pawlik
Journal:  JAMA Surg       Date:  2021-07-01       Impact factor: 14.766

Review 9.  Neoadjuvant Therapy of Pancreatic Cancer: Definitions and Benefits.

Authors:  Stefan Heinrich; Hauke Lang
Journal:  Int J Mol Sci       Date:  2017-07-26       Impact factor: 5.923

10.  Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study.

Authors:  Stefan Heinrich; Marc Besselink; Markus Moehler; Jean-Luc van Laethem; Michel Ducreux; Peter Grimminger; Jens Mittler; Hauke Lang; Manfred P Lutz; Mickael Lesurtel
Journal:  BMC Cancer       Date:  2019-07-09       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.